Recording of M4K Pharma’s Scientific Update Meeting – May 8th, 2019

By | 2019-05-16T15:18:36+00:00 May 16th, 2019|

Listen to a recording of the May 2019 Scientific Update Meeting Listen to M4K Pharma's Scientific Update Meeting from May 8th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]

M4ND Pharma: Open science drug discovery model expands to neurodegenerative diseases

By | 2019-03-01T20:04:00+00:00 February 16th, 2019|

Medicines for Neurodegeneration (M4ND) Pharma launched! Following in the path of M4K Pharma, M4ND will tackle neurodegenerative diseases such as Parkinson’s disease, thanks to funding from the Krembil Foundation, and will commit to open science practises, open sharing of data, and affordable pricing. https://www.utoronto.ca/news/u-t-researcher-s-open-science-drug-discovery-model-expands-neurodegenerative-diseases